<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to their <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) subtypes show distinct molecular parameters </plain></SENT>
<SENT sid="1" pm="."><plain>Hereditary non-polypous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (HNPCC) is the most common inherited <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> characterized by clinical criteria and confirmed microsatellite instability (MSI) </plain></SENT>
<SENT sid="2" pm="."><plain>Interestingly, a recently identified subtype, familial <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> type X (FCC-X), shows the same clinical criteria but microsatellite stability (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>CEACAM1 is a known <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor that regulates <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in colon cells, and its loss is one of the most frequent events in early <z:mp ids='MP_0002006'>tumorigenesis</z:mp> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore its loss may characterize precursor colon cells prior to <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>We analyzed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> specimens of HNPCC and FCC-X patients in order to investigate whether there is a loss of CEACAM1 expression analogous to <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and whether the expression of CEACAM1 would distinguish between these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> entities </plain></SENT>
<SENT sid="6" pm="."><plain>No differences in CEACAM1 expression were noted between HNPPC (n = 38) and FCC-X (n = 30) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CEACAM1 was reduced in near-identical frequencies in 36/38 (95%) HNPCC and 29/30 (97%) FCC-X </plain></SENT>
<SENT sid="8" pm="."><plain>This is the first report to demonstrate the loss of CEACAM1 expression in hereditary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>There was no difference between HNPCC and FCC-X </plain></SENT>
<SENT sid="10" pm="."><plain>The frequency of expression loss was comparable to <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, indicating that loss of CEACAM1 is an early event in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> linking the genesis of <z:hpo ids='HP_0003745'>sporadic</z:hpo> and hereditary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>